Table 2.
Centers characteristics at first hospital stay (N = 3650 patients).
| OverallN (%) | Surgery group N (%) | Chemotherapy group N (%) | Best supportive care group N (%) | |
|---|---|---|---|---|
| Global population with iCCA+ | 3650 (100) | 410 (11,2) | 869 (23,8) | 2 371 (65,0) |
| Entry mode by emergency room | 994 (28·4) | 28 (6·9%) | 104 (12·2) | 862 (38·4) |
| Type of establishment | ||||
| Cancer center (CLCC) | 218 (6·0) | 27 (6·6) | 108 (12·4) | 83 (3·5) |
| University Hospital (CHU) | 549 (15·0) | 94 (22·9) | 138 (15·9) | 317 (13·4) |
| General Hospital (CHG) | 2 184 (59·8) | 213 (52·0) | 462 (53·2) | 1 509 (63·6) |
| Private centers | 699 (19·2) | 76 (18·5) | 161 (18·5) | 462 (19·5) |
| Volume of centers * | ||||
| Low (<5 patients) | 1052 (28·8) | 63 (15·4) | 220 (25·3) | 769 (32·4) |
| Intermediate (5–20 patients) | 1551 (42·5) | 123 (30·0) | 391 (45·0) | 1037 (43·7) |
| High (>20 patients) | 1047 (28·7) | 224 (54·6) | 258 (29·7) | 565 (23·8) |
+iCCA : intra-hepatic cholangiocarcinoma; *Number of patients identified during the 2014–2015 period.
All statistical tests between columns are statistically significant at 0·05%.